Literature DB >> 21765030

IL-17 in cystic fibrosis: more than just Th17 cells.

Patricia J Dubin, Jay K Kolls.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21765030     DOI： 10.1164/rccm.201104-0617ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.

Authors:  Daniel Hsu; Patricia Taylor; Dave Fletcher; Rolf van Heeckeren; Jean Eastman; Anna van Heeckeren; Pamela Davis; James F Chmiel; Eric Pearlman; Tracey L Bonfield
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

2.  Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.

Authors:  Emanuela M Bruscia; Ping-Xia Zhang; Christina Barone; Bob J Scholte; Robert Homer; Diane S Krause; Marie E Egan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-05       Impact factor: 5.464

Review 3.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

4.  Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection.

Authors:  T L Bonfield; C A Hodges; C U Cotton; M L Drumm
Journal:  J Leukoc Biol       Date:  2012-08-02       Impact factor: 4.962

Review 5.  T cell-mediated host immune defenses in the lung.

Authors:  Kong Chen; Jay K Kolls
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

6.  Spelunking in Sputum: Single-Cell RNA Sequencing Sheds New Insights into Cystic Fibrosis.

Authors:  Naoki Iwanaga; Jay K Kolls
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

7.  Type 2 inflammation in cystic fibrosis: New insights.

Authors:  Sara Manti; Giuseppe Fabio Parisi; Maria Papale; Gian Luigi Marseglia; Amelia Licari; Salvatore Leonardi
Journal:  Pediatr Allergy Immunol       Date:  2022-01       Impact factor: 5.464

8.  IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa.

Authors:  Nicola Ivan Lorè; Cristina Cigana; Camilla Riva; Ida De Fino; Alessandro Nonis; Lorenza Spagnuolo; Barbara Sipione; Lisa Cariani; Daniela Girelli; Giacomo Rossi; Veronica Basso; Carla Colombo; Anna Mondino; Alessandra Bragonzi
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

Review 9.  Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis.

Authors:  Balázs Rada
Journal:  Pathogens       Date:  2017-03-09

Review 10.  Immunomodulation in Cystic Fibrosis: Why and How?

Authors:  Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.